[ Price : $8.95]
FDA and the device industry are nearing a final agreement on the next round of Medical Device User Fee Act (MDUFA VI) negotiations...[ Price : $8.95]
Medline Industries recalls (Class 1) its angiographic control syringes, warning the devices could cause severe injury or death.[ Price : $8.95]
Two Hyman, Phelps & McNamara attorneys describe the impacts on industry if FDA responds to a congressional push for more pre-revie...[ Price : $8.95]
HHS secretary Robert F. Kennedy Jr. curtails his public commentary on vaccines as part of a deliberate political strategy by the T...[ Price : $8.95]
The CDER Office of Prescription Drug Promotion says an Amneal patient brochure for its Avastin biosimilar Alymsys is false or misl...[ Price : $8.95]
Minutes of the 3/10 and 3/12 PDUFA 8 reauthorization steering committee sessions, progress was reported on the America First fee i...[ Price : $8.95]
Granules India Ltd tightens oversight of its manufacturing operations at its largest facility based on FDA-documented compliance i...[ Price : $8.95]
FDA cites GMP deficiencies at a facility operated by Thermo Fisher Scientific (Patheon Italia unit) in Ferentino, Italy.